智通财经APP讯，威高股份(01066)发布公告，于2026年1月16日，该公司斥资174.25万港元回购32万 股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 山東威高集團醫用高分子製品股份有限公司 呈交日期： 2026年1月16日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01066 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 ...

Core Viewpoint - The case highlights the issue of commercial bribery in the pharmaceutical industry, specifically involving a sales representative from Shandong Weigao Group Medical Polymer Co., Ltd., who engaged in bribery to influence prescription practices and disrupt fair competition in the healthcare sector [5][7]. Group 1: Bribery Details - The sales representative, Ci Mou Long, was found guilty of bribing staff at the Pu'er People's Hospital with a total of RMB 1,195,243 in cash and goods, including cash payments of RMB 395,000 and USD 9,900, as well as a gold bar weighing 200 grams [5][8]. - Between 2012 and 2020, Ci Mou Long made multiple payments to various hospital staff, including a total of RMB 290,000 in cash and a gold bar to the hospital's chief accountant, Liu Mou Wen, for facilitating payment settlements [8]. - The bribery involved various medical supplies, with cash kickbacks totaling RMB 408,200 and 500 supermarket vouchers distributed among nursing staff across different departments [13]. Group 2: Legal Consequences - Ci Mou Long was sentenced to 2 years and 6 months in prison and fined RMB 200,000 for his actions [7]. - The National Healthcare Security Administration (NHSA) plans to guide local healthcare authorities in conducting credit evaluations and enforcing measures against untrustworthy companies to protect healthcare fund security [7]. Group 3: Industry Implications - The NHSA has been actively reporting multiple cases of commercial bribery in the pharmaceutical sector to warn against unethical practices that undermine the integrity of medical services and increase healthcare costs [6].

智通财经APP讯，威高股份(01066)发布公告，于2026年1月15日斥资99.08万港元回购18万股。 ...

威高股份(01066)发布公告，于2026年1月15日斥资99.08万港元回购18万股。 ...

格隆汇1月15日丨威高股份(01066.HK)发布公告，2026年1月15日耗资99.1万港元回购18万股，回购价格 每股5.49-5.52港元。 ...

如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01066 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | 事件 | | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2026年1月14日 | 4,486,024,724 | | 36,3 ...

智通财经APP讯，威高股份(01066)发布公告，于2026年1月14日斥资121.5万港元回购22万股。 ...

表格類別： 股票 狀態： 新提交 FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 公司名稱： 山東威高集團醫用高分子製品股份有限公司 呈交日期： 2026年1月14日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01066 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股 ...

Group 1 - The article discusses the share buybacks conducted by various companies on January 13, 2026, with Tencent Holdings (00700) having the largest buyback amount of 636 million yuan for 1.012 million shares [1][2] - Other notable companies involved in the buyback include Xiaomi Group (01810) with 4 million shares repurchased for 152 million yuan, and Sunny Optical Technology (02382) with 640,000 shares for approximately 41.79 million yuan [1][2] - The total number of shares repurchased by Tencent Holdings in the year reached 11 million, representing 1.199% of its total share capital [2] Group 2 - The buyback activities reflect a strategic move by companies to enhance shareholder value and signal confidence in their financial health [1][2] - Companies like Weigao Group (01066) and Xinli International (00732) also showed significant buyback activity, with Weigao repurchasing 27,440 shares for 1.4962 million yuan, representing 6.519% of its total share capital [2] - The data indicates a trend among companies to engage in share buybacks as a method to return capital to shareholders and potentially boost stock prices [1][2][3]